Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Walgreens

Which stock wins in a battle between these two retail pharmacy giants?

Better Buy:  Walgreens Boots Alliance vs. Rite Aid

Rite Aid Hits Home Run With Heyward

RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.

Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term

Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.

The Comfort Zone Is Holding Rite Aid Stock Back

Care.com

GoPro

iRobot

Under Armour

Alphabet saved FIT stock with a big buyout, and these five stocks to buy could be next to be saved by an acquisition.

5 Beaten-Up Stocks to Buy That Could Be Saved By An Acquisition

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Up 8.9% Since Last Earnings Report: Can It Continue?

CVS Health

Johnson & Johnson

Walmart

Walmart, CVS and Rite Aid have pulled some or all 22-ounce bottles of Johnson’s baby powder from shelves to avoid confusing consumers, after a minuscule amount of asbestos was found in one bottle. Johnson & Johnson recalled all 33,000 bottles from the same lot as that bottle last Friday, a day after the US Food.

Retailers pull Johnson’s baby powder after recall

CVS Health Corp and Rite Aid Corp are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to possible asbestos contamination.

CVS, Rite Aid pull all 22-ounce J&J baby powder from stores

Blue Apron

Fitbit

GameStop

Groupon

Pier 1 Imports

These eight penny stocks have gone from winners to losers, and while some of them could go back to being winners, not all of them will.

8 Penny Stocks That Have Fallen From Grace

Rite Aid continued to rally despite a 31% short float against the stock.

Rite Aid: On The Rebound

Macy's

Signet Jewelers

History says that Sell ratings from Wall Street are meaningful and predictive, so investors should shy away from these five stocks to sell.

5 Stocks to Sell Now, According to Wall Street

Ascena Retail Group

A weakening retail landscape has sunk over a dozen big-name retailers so far, and there are plenty of candidates that may follow suit.

3 Big Retail Bankruptcies of 2019 -- and 4 More That May Be Next

RAD stock both rallied by 50% and dropped by 30% in September - and none of it had anything to do with the fundamentals of Rite Aid stock, which remain bad.
The post The Roller Coaster Ride of Rite Aid Stock Is Much Ado About Nothing appeared first on InvestorPlace.

The Roller Coaster Ride of Rite Aid Stock Is Much Ado About Nothing

At Home Group

Stamps.com

Tilray Brands

The market's trading higher this year, but some stocks have not been playing along.

5 Stocks That Have Been Cut in Half So Far in 2019

Rite Aid stock may complete a basing pattern after a brutal three-year downtrend and rally 50% in coming months.

Battered Rite Aid Stock Could Reward Bottom Fishers

Rite Aid Corp. RAD, -1.15% announced the appointment of Jim Peters as chief operating officer on Wednesday, in charge of the company's pharmacy business and clinical strategy.

Rite Aid names Jim Peters COO

Rite Aid stock – don’t wait for any management-led turnaround. This pharmacy retailer is laden with debt, cash flow losses and no clear turnaround plan.

There’s No Management Turnaround That Will Boost Rite Aid Stock

Rather than trying desperately to find a buyer, Rite Aid will leverage their core strengths to bring value-add to their business. This is probably the best play available for Rite Aid stock.

Are Health Plans the Key to Rite Aid’s Savior?

With this in mind, the stock is a hard pass. Investors likely can find more solid turnaround plays elsewhere.

With Any Turnaround Already Priced In, Avoid Rite Aid Stock

Rite Aid (NYSE:RAD) jumped more than 20% last week after exceeding second-quarter earnings guidance. The boost came at a good time.

The Q2 Earnings Bump Is Not a Signal to Buy Rite Aid Stock

Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.

Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q2 2020 Results - Earnings Call Transcript

Rite Aid (RAD) earnings for the second quarter of fiscal 2020 have RAD stock taking off on Thursday on a strong EPS beat.
The post Rite Aid Earnings: RAD Stock Soars 5% on Q2 Beat appeared first on InvestorPlace.

Rite Aid Earnings: RAD Stock Soars 5% on Q2 Beat

After mixed second-quarter results and remaining challenges, investors need more long-term assurance.

Is Rite Aid's 23% Pop on Thursday Warranted?

Shares of drugstore chain Rite Aid Corp. (NYSE:RAD) rose 9% in premarket trading on Thursday after reporting second-quarter 2020 financial results.

News for Rite Aid Stock (RAD)